Cognitive Dysfunction Screening in Peritoneal Dialysis Patients: A Cross-Sectional Study

Ana C Brás1, Joana Marques2, Vasco Fernandes2

  • 1Department of Nephrology, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal.

PubMed
Abstract

Insights

Mild cognitive impairment (MCI) affects over half of peritoneal dialysis (PD) patients, linked to poorer health outcomes. Key risk factors include advanced age, low education, and reduced dialysis efficiency (Kt/V, nPCR).

Area of Science:

  • Nephrology
  • Neurology
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) is a known risk factor for adverse outcomes in peritoneal dialysis (PD) patients, including peritonitis, technique failure, and mortality.
  • Understanding the prevalence and risk factors of MCI in PD patients is crucial for improving patient management and outcomes.

Purpose of the Study:

  • To determine the prevalence of MCI in a PD patient population.
  • To identify potential risk factors associated with MCI in PD patients.

Main Methods:

  • An observational, cross-sectional study was conducted.
  • Cognitive function was assessed using the Montreal Cognitive Assessment (MOCA) and Mini-Mental State Examination (MMSE) tests.
  • Exclusion criteria included dementia, severe neurologic impairment, active cancer, or infection.

Main Results:

  • MCI prevalence was 65% (MOCA) and 33% (MMSE) in 66 PD patients (mean age 60, 53% male).
  • Predictors of MCI included higher age, lower education, need for a helper, and continuous ambulatory PD modality.
  • Higher comorbidity index, coronary artery disease, peripheral artery disease, lower Kt/V, and lower normalized protein catabolic rate (nPCR) were associated with MCI.
  • MCI patients experienced more peritonitis episodes.

Conclusions:

  • MCI is highly prevalent in PD patients, affecting over half the cohort.
  • MCI is associated with older age, lower education, increased disease burden, and a higher risk of peritonitis.
  • Lower dialysis adequacy (Kt/V) and reduced protein catabolism (nPCR) are significant factors linked to MCI in PD patients.